Significance of HER2 Low-Level Copy Gain in Barrett's Cancer: Implications for Fluorescence In situ Hybridization Testing in Tissues
Lists
Only you see this
Abstract
Low-level copy gains of HER2 define a biologically distinct subpopulation of Barrett's cancer patients. Importantly, these subtle copy number changes are not reliably detected by standard FISH in thin (4 microm) tissue sections, highlighting a thus far unrecognized weakness in HER2 FISH testing. These results should be taken into account for accurate evaluation of biomarkers by FISH and for HER2 FISH testing in tissue sections.
BibTeX
@inproceedings{rauser2007significance,
author = {Sandra Rauser and Roland Weís and Herbert Braselmann and Marcus Feith and H. J. Stein and Rupert Langer and Peter Hutzler and Michael Hausmann and Silke Laßmann and J. R. Siewert and Heinz Höfler and Martin Werner and Axel Walch},
title = {{Significance of HER2 Low-Level Copy Gain in Barrett's Cancer: Implications for Fluorescence <i>In situ</i> Hybridization Testing in Tissues}},
booktitle = {Clinical},
year = {2007},
doi = {10.1158/1078-0432.ccr-07-0465},
}Loading related content...